The role of somatostatin in vasogenic meningioma associated brain edema

Many tumors, including meningiomas, express somatostatin receptors, suggesting the application of somatostatin analogues for therapy and diagnosis. Sixty percent of meningiomas are associated with perilesional edema, whose development seems to be related to the vascular endothelial growth factor, al...

Full description

Saved in:
Bibliographic Details
Published in:Tumori Vol. 89; no. 2; pp. 136 - 140
Main Authors: Pistolesi, Sabina, Fontanini, Gabriella, Boldrini, Laura, Camacci, Tiziano, De Ieso, Katia, Lupi, Giancarlo, Caniglia, Michele, Mariani, Giuliano, Boni, Giuseppe, Suriano, Sergio, Padolecchia, Riccardo, Pingitore, Raffaele, Parenti, Giuliano
Format: Journal Article
Language:English
Published: United States 01-03-2003
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Many tumors, including meningiomas, express somatostatin receptors, suggesting the application of somatostatin analogues for therapy and diagnosis. Sixty percent of meningiomas are associated with perilesional edema, whose development seems to be related to the vascular endothelial growth factor, although it requires an efficient pial blood supply. However, in several neoplastic models, other mediators seem to cooperate with vascular endothelial growth factor in regulating angiogenesis. We evaluated somatostatin receptors (sst2) in relation to the possibility that somatostatin analogues may influence vascular endothelial growth factor production with reduction of edema. Of 35 studied meningiomas, 21 presented peritumoural edema. Vascular endothelial growth factor, microvascular density and pial blood supply were significantly related to the edema (P = 0.0001, P = 0.0001, P = 0.0005). Similarly, a relation was found between sst2 and microvascular density (r = 0.58, P < 0.001) and between sst2 and vascular endothelial growth factor expression (P = 0.03). This suggests that somatostatin analogues may be relevant for the treatment of meningiomas.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0300-8916
2038-2529
DOI:10.1177/030089160308900206